4.1.1.9	5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside	AMP-activated protein kinase activator, 2fold activation of MCD in extensor digitorum longus, reversed by protein phosphatase A	652024	
4.1.1.9	Alkaline phosphatase	treatment with alkaline phosphatase enhances MCD activity suggesting phosphorylation-related control of enzyme	649690	
4.1.1.9	AMP-activated potein kinase	AMP-activated potein kinase activates MCD by phosphorylation	691964	
4.1.1.9	DL-carnitine	stimulates	4845	
4.1.1.9	fatty acid	increases MCD expression in heart and skeletal muscle	649300	
4.1.1.9	fenofibrate	increases hepatic mRNA expression and MCD activity	649775	
4.1.1.9	iodoacetamide	malonyl-decarboxylase activity is induced by treatment of fatty acid synthetase with iodoacetamide	4848	
4.1.1.9	iodoacetamide	treatment of fatty acid synthetase with iodoacetamide induces malonyl-CoA decarboxylase activity and impairs the synthetase activity	4855	
4.1.1.9	additional information	gastrocnemius contraction activates MCD, reversed by protein phosphatase A or by omitting phosphatase inhibitors from assay mixture, increase of MCD activity after skeletal muscle contraction is likely due to its phosphorylation by AMP-activated protein kinase	652024	
4.1.1.9	additional information	high-fat feeding, fasting and streptozotocin-induced diabetes increase the plasma concentration of nonesterified fatty acids, with a concomitant increase in both heart and skeletal muscle MCD mRNA	649300	
4.1.1.9	additional information	MCD activity is elevated under conditions in which hepatic fatty acid oxidation is known to increase, such as streptozotocin-induced diabetes or following a 48 h fast, 2fold increase in expression in streptozotocin-diabetic rats compared with controls	649690	
4.1.1.9	additional information	peroxisomal-proliferator-activated receptor alpha activates transcription of hepatic MCD gene by binding of peroxisomal-proliferator-activated receptor alpha/retinoid X receptor alpha on two PPRE sites, WY14643-treated H4IIE hepatoma cells show increased MCD mRNA expression	649775	
4.1.1.9	additional information	there is an age-dependent increase in expression of MCD manifesting maturation of fatty acid metabolism in the newborn human heart	694551	
4.1.1.9	palmitate	the activity of MCD elicits a dose-dependent increase (between 25% and 60%) in cells exposed to increasing concentrations of palmitate (0.1-0.8 mM)	693327	
4.1.1.9	phosphate	activates	4845	
4.1.1.9	WY-14643	specifically stimulates the peroxisome proliferator-activated receptor-alpha increasing MCD expression and activity in heart and skeletal muscle	649300